St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the first quarter ended March 30, 2013.
“We are pleased with our track record of delivering strong earnings per share growth while we continue to invest in our diversified product portfolio. We expect sales growth to accelerate as we launch more than 20 new products to the market in 2013.”
